First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer
Article in ACS Pharmacology & Translational Science (June 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in ACS Pharmacology & Translational Science (June 2023)
Article in JNCI Cancer Spectrum (March 2023)
Article in Frontiers in Oncology (July 2022)